• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Anavex Life Sciences Corp. - Common Stock (NQ:AVXL)

1.455 -0.085 (-5.52%)
Delayed Quote Updated: 1:48 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 639,884
Open 1.540
Bid (Size) 1.450 (7,900)
Ask (Size) 1.460 (2,100)
Prev. Close 1.540
Today's Range 1.440 - 1.540
52wk Range 1.500 - 10.10
Shares Outstanding 89,348,107
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Deadline Alert: Anavex Life Sciences Corp. (AVXL) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
October 08, 2026
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
AVXL SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Anavex (NASDAQ: AVXL) Investors of Securities Class Action Lawsuit Deadline on November 30, 2026
October 07, 2026
From Faruqi & Faruqi LLP
Via GlobeNewswire

Performance

52-Week Range 85.6% below 52-week high
1.455
1.5052W Low 10.1052W High
1 Week 22.6% below 1-week high
1.501W Low 1.881W High

Anavex Life Sciences Corp. - Common Stock (AVXL) traded between $1.50 and $10.10 over the past 52 weeks and last traded at $1.46, 85.6% below its 52-week high. Over the past week it ranged between $1.50 and $1.88.

Past 12 Months
-20.1%
-48.9%
-46.1%
-52.3%
-60.5%
-85.2%
1W -$0.36
1M -$1.40
3M -$1.25
6M -$1.59
YTD -$2.23
1Y -$8.39

AVXL was -85.2% over the past year, -52.3% over six months, -60.5% year to date, -20.1% in the last week.

12 Months vs Market
AVXL
-85.2%
DIA
+10.7%
SPY
+15.6%
QQQ
+22.8%
IWM
+13.1%

Over the past 12 months AVXL returned -85.2% versus DIA (Dow) +10.7%, SPY (S&P 500) +15.6%, QQQ (Nasdaq 100) +22.8% and IWM (Russell 2000) +13.1%.

Volume & Liquidity 0.65× 3-mo avg
Today 639,884 3-mo avg 978.7K
1W
1.7M
1M
1.1M
3M
978.7K
6M
1.1M
YTD
1.2M
1Y
1.6M

AVXL most recently traded 639,884 shares against a 3-month average daily volume of 978.7K.

More News

Read More
News headline image
Deadline Approaching: Anavex Life Sciences Corp. (AVXL) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
October 07, 2026
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Kaplan Fox Encourages Investors of Anavex Life Sciences Corp. (NASDAQ: AVXL) to Contact the Firm to Learn About Their Legal Rights
October 07, 2026
Via NewMediaWire
Topics Lawsuit Regulatory Compliance
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Anavex Life Sciences Corp. of Class Action Lawsuit and Upcoming Deadlines – AVXL
October 06, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Deadline Soon: Anavex Life Sciences Corp. (AVXL) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
October 06, 2026
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit with SBS Law
October 06, 2026
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
ROSEN, THE FIRST FILING FIRM, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXL
October 05, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
ANAVEX CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Anavex Life Sciences Corp. and Encourages Investors to Contact the Firm
October 05, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Anavex Life Sciences Corp. (AVXL) Shareholders To Inquire About Securities Fraud Class Action
October 05, 2026
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
Law Offices of Howard G. Smith Encourages Anavex Life Sciences Corp. (AVXL) Shareholders To Inquire About Securities Fraud Class Action
October 05, 2026
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Important Notice to Long-Term Shareholders of Anavex Life Sciences Corp. (NASDAQ: AVXL); Ardelyx, Inc. (NASDAQ: ARDX); Aardvark Therapeutics, Inc. (NASDAQ: AARD); and GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI): Grabar Law Office is Investigating
October 05, 2026
From Grabar Law Office
Via GlobeNewswire
News headline image
ROSEN, THE FIRST FILING FIRM, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXL
October 02, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
AVXL Shareholder Alert: November 30, 2026 Lead Plaintiff Deadline in Anavex Life Sciences Corp. Securities Class Action - Contact Levi & Korsinsky
October 02, 2026
From Levi & Korsinsky, LLP
Via ACCESS Newswire
News headline image
AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit with SBS Law
October 02, 2026
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
Law Offices of Frank R. Cruz Encourages Anavex Life Sciences Corp. (AVXL) Shareholders To Inquire About Securities Fraud Class Action
October 01, 2026
From Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Securities Fraud Investigation Into Anavex Life Sciences Corp. (AVXL) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
October 01, 2026
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
Anavex Life Sciences Corp. (AVXL) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
October 01, 2026
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Securities Class Action Filed Against Anavex Life Sciences Corp. – AVXL Investors Encouraged to Contact Kirby McInerney LLP
September 30, 2026
From Kirby McInerney LLP
Via Business Wire
News headline image
Securities Fraud Investigation Into Anavex Life Sciences Corp. (AVXL) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
September 30, 2026
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Anavex Life Sciences Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – AVXL
September 30, 2026
From The DJS Law Group
Via Business Wire
News headline image
AVXL INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Anavex Life Sciences Corp. Investors – Holzer & Holzer, LLC Encourages Investors With Losses to Contact the Firm
September 30, 2026
From Holzer & Holzer
Via GlobeNewswire
News headline image
AVXL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Anavex (NASDAQ: AVXL) Investors of Securities Class Action Lawsuit Deadline on November 30, 2026
September 30, 2026
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
Stockholder Alert: Robbins LLP Informs Investors of the Anavex Life Sciences Corp. Class Action Lawsuit
September 30, 2026
From Robbins LLP
Via Business Wire
News headline image
AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit with SBS Law
September 30, 2026
From Schall, Brown & Schwartz LLP
Via Business Wire

Frequently Asked Questions

Is Anavex Life Sciences Corp. - Common Stock publicly traded?
Yes, Anavex Life Sciences Corp. - Common Stock is publicly traded.
What exchange does Anavex Life Sciences Corp. - Common Stock trade on?
Anavex Life Sciences Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Anavex Life Sciences Corp. - Common Stock?
The ticker symbol for Anavex Life Sciences Corp. - Common Stock is AVXL on the Nasdaq Stock Market
What is the current price of Anavex Life Sciences Corp. - Common Stock?
The current price of Anavex Life Sciences Corp. - Common Stock is 1.455
When was Anavex Life Sciences Corp. - Common Stock last traded?
The last trade of Anavex Life Sciences Corp. - Common Stock was at 10/09/26 01:48 PM ET
What is the market capitalization of Anavex Life Sciences Corp. - Common Stock?
The market capitalization of Anavex Life Sciences Corp. - Common Stock is 130.00M
How many shares of Anavex Life Sciences Corp. - Common Stock are outstanding?
Anavex Life Sciences Corp. - Common Stock has 130M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap